"Anemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Descriptor ID |
D000740
|
MeSH Number(s) |
C15.378.071
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anemia".
Below are MeSH descriptors whose meaning is more specific than "Anemia".
This graph shows the total number of publications written about "Anemia" by people in this website by year, and whether "Anemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 2 | 3 |
1997 | 2 | 1 | 3 |
1998 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2001 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 3 | 3 |
2007 | 0 | 4 | 4 |
2008 | 2 | 2 | 4 |
2009 | 1 | 6 | 7 |
2010 | 1 | 4 | 5 |
2011 | 2 | 1 | 3 |
2012 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2014 | 1 | 2 | 3 |
2015 | 1 | 1 | 2 |
2016 | 1 | 3 | 4 |
2017 | 1 | 2 | 3 |
2018 | 3 | 3 | 6 |
2020 | 5 | 4 | 9 |
2022 | 5 | 0 | 5 |
2023 | 4 | 0 | 4 |
2024 | 6 | 0 | 6 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia" by people in Profiles.
-
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr; 282:146-155.
-
Missed opportunities: Lack of a diagnostic workup of anaemia results in a high prevalence of unidentified anaemia. Vox Sang. 2025 Feb; 120(2):163-169.
-
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial. JAMA Netw Open. 2024 Nov 04; 7(11):e2442361.
-
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis. Blood. 2024 10 24; 144(17):1813-1820.
-
Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 03; 150(23):1826-1836.
-
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Jun; 25(6):752-768.
-
Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline. Int J Gynaecol Obstet. 2024 May; 165(2):431-441.
-
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N Engl J Med. 2023 Dec 28; 389(26):2446-2456.
-
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
-
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials. Clin Exp Nephrol. 2023 Aug; 27(8):651-659.